Logo
SearchSearch
Languages
Language
LoginSign up
Invest in Cara Therapeutics
Today
Create an eToro account to buy CARA stock on a secure, user-friendly, multi-asset trading platform.
Buy Cara Therapeutics
CARA Price
Cara Therapeutics CARA
CARA Price

Cara Therapeutics CARA

$0.25-0.03(-9.51%)(1D)

CARA Stock Price Chart

-7.21%
Past Month
1D
1W
1M
6M
1Y
3Y
MAX
Sign up for full charts powered byTradingView logo
*Past performance is not an indication of future results
Asset negative trend

The Cara Therapeutics share price is on the decline this week.

i
A ‘rising’ price indicates that the weekly price has increased by more than 0.5%.
A price ‘on the decline’ indicates that the weekly price has decreased by more than 0.5%.
A ‘stable’ price indicates that the change in weekly price is between -0.5% and 0.5%.
The Cara Therapeutics share price today is 0.25, reflecting a -9.51% change over the last 24 hours and -6.38% over the past week. The current market capitalization of CARA is 15.03M with an average volume in the last three months of 531675.64. The stock has a P/E ratio of -0.16 and a dividend yield of 0%. With the stock’s beta sitting at 1.3
Market Cap
i
Total value of all asset shares, calculated by multiplying the price by the total number of outstanding shares.
$15.03M

Day’s Range
i
Shows the high and low prices of the day.
0.24 - 0.33

52W Range
i
Shows the high and low prices of the last year.
0.22 - 4.43

Average Volume (3M)
i
The average number of shares traded per day over the last three months.
531675.64

Price-Earnings Ratio
i
The result of this asset’s share price divided by its earnings per share.
-0.16

Revenue
i
The total income generated by this company’s goods and services last year.
$8.69M

Dividend (Yield)
i
How much a company pays out in dividends each year relative to its stock price.
0 (0%)

Prev Close
i
The final price of this asset at the end of the last trading day.
$0.27

EPS
i
A company’s total earnings divided by the number of shares it has issued.
-1.75

Beta
i
A measure of whether any asset does, or doesn’t, experience price moves in line with the broader market.
1.3

What Is Cara Therapeutics ?
Cara Therapeutics Inc is a clinical-stage specialist biopharmaceutical company engaged in the discovery, development, and commercialisation of pharmaceutical solutions. It focuses on peripheral nervous system pain relief by selectively targeting the body’s peripheral kappa opioid receptors. The main focus of the company’s work is pursuing novel pruritus therapies to transform the way the condition is treated and improve the quality of life for those who suffer from it. Operating globally, the firm has its headquarters in Stamford, Connecticut, and was founded in 2004.

The firm’s main commercial product is KORSUVA, a medication administered by injection that is designed to treat patients suffering with moderate to severe pruritus as a result of chronic kidney disease. The firm has other products in its pipeline undergoing clinical trials, including oral therapies for patients with pruritus. The firm primarily aims to treat patients suffering from pruritis as a result of chronic kidney disease and chronic liver disease.

The company runs regular clinical trials as part of its rigorous research programmes, and patients are encouraged to get in touch if they would like to participate. The firm is listed on the NASDAQ, where it trades under the ticker CARA.

Follow the CARA share price on eToro by adding this stock to your eToro watchlist.

How can I buy Cara Therapeutics stocks?

To purchase Cara Therapeutics :
01

Create an eToro account:

Sign up for an eToro account and verify your identity.
02

Deposit funds:

Deposit funds into your eToro account using your preferred payment method.
03

Search and purchase:

Search the Cara Therapeutics (CARA) page and place an order to buy Cara Therapeutics .
Looking for more information? Check out our guide on Academy.
Top Guides
Our top picks for the most relevant guides from the eToro Academy
Top Dividend Stocks for 2024
Top Dividend Stocks for 2024
In times of market volatility, dividend investing provides investors with a steady source of income. eToro presents the top 6 dividend stocks to consider.
Read More
Stock Trading And Investing For Beginners
Stock Trading And Investing For Beginners
New to online trading? Learn the basics with eToro. What are stocks? trading vs. investing, what are the risks, and how to open a trade, step by step.
Read More
AI Stocks Poised for Growth in 2024
AI Stocks Poised for Growth in 2024
Gear up for 2024 with a focus on AI stocks. Dive into the promising growth of C3.ai, Palantir Technologies, CrowdStrike, through eToro's expert analysis.
Read More
Graph
Buy Cara Therapeutics
Invest in Cara Therapeutics
Today
Create an eToro account to buy CARA stock on a secure, user-friendly, multi-asset trading platform.

FAQ

The current price of CARA is 0.25.
The average price target for Cara Therapeutics is 0.25. Sign up to eToro for detailed analyst forecasts and price targets.
Analysts offer forecasts for Cara Therapeutics based on market trends, financial reports and projected growth. Check the latest forecast for future price movements.
The market capitalisation of Cara Therapeutics is 15.03M
Select the "1D" or "1W" timeframe on the eToro chart and zoom out to see the historical price movements of Cara Therapeutics . The price of Cara Therapeutics has ranged between 0.22 and 4.43 over the last year.
To buy CARA, visit the "Cara Therapeutics (CARA)" page. Once you have created an account and deposited funds, click the "Trade" button and decide how much Cara Therapeutics you want to purchase. You can also place an order that will buy CARA at a specific price in the future.
Scroll to top